山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (7): 120-124.doi: 10.6040/j.issn.1671-7554.0.2024.0232
• 病例报道 • 上一篇
宋艳艳,左淑英
中图分类号:
| [1] Wu F, Xia CW, Hai R, et al. Papillary thyroid carcinoma with clear cell renal cell carcinoma metastasized to the thyroid gland: a case report[J]. Oncol Lett, 2023, 26(6): 528. [2] Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma[J]. Am J Surg Pathol, 2003, 27(5): 612-624. [3] Miah MS, White SJ, Oommen G, et al. Late simultaneous metastasis of renal cell carcinoma to the submandibular and thyroid glands seven years after radical nephrectomy[J]. Int J Otolaryngol, 2010, 2010: 698014. doi:10.1155/2010/698014. [4] Moudouni SM, Tligui M, Doublet JD, et al. Late metastasis of renal cell carcinoma to the submaxillary gland 10 years after radical nephrectomy[J]. Int J Urol, 2006, 13(4): 431-432. [5] Balaban M, Dogruyol SV, Idilman IS, et al. Renal cell carcinoma metastasis to ipsilateral parotid and submandibular glands: report of a case with sonoelastographic findings[J]. Pol J Radiol, 2016, 81: 17-20. doi:10.12659/PJR.895430. [6] Serouya SM, Dultz LA, Concors SJ, et al. Late solitary metastasis of renal cell carcinoma to the submandibular gland[J]. J Oral Maxillofac Surg, 2012, 70(10): 2356-2359. [7] Majewska H, Skálová A, Radecka K, et al. Renal clear cell carcinoma metastasis to salivary glands - a series of 9 cases: clinico-pathological study[J]. Pol J Pathol, 2016, 67(1): 39-45. [8] Ficarra G, Pierleoni L, Panzoni E. Metastatic renal cell carcinoma involving Wharton’s duct: a case report[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 81(5): 580-583. [9] Barnes, Leon, Eveson, et al. WHO organization classification of tumors. Pathology and genetics of head and neck tumors[M]. 3th ed. Lyon: IARC Press, 2005: 430. [10] 周嫔, 叶恩如, 杨佩浓, 等. 肾透明细胞癌术后10年转移至颌下腺1例[J]. 浙江医学, 2020, 42(24): 2693-2694. ZHOU Pin, YE Enru, YANG Peinong, et al. Metastasis of renal clear cell carcinoma to submandibular gland 10 years after operation: a case report[J]. Zhejiang Medical Journal, 2020, 42(24): 2693-2694. [11] Smits JG, Slootweg PJ. Renal cell carcinoma with metastasis to the submandibular and parotid glands. A case report[J]. J Maxillofac Surg, 1984, 12(5): 235-236. [12] Bedrosian SA, Goldman RL, Dekelboum AM. Renal carcinoma presenting as a primary submandibular gland tumor[J]. Oral Surg Oral Med Oral Pathol, 1984, 58(6): 699-701. [13] Higuera F, Boccalatte LA, Labanca J, et al. Renal clear cell carcinoma metastasis to submandibular gland: case report and review of the literature[J]. J Surg Case Rep, 2018(10):261. [14] Liu F, Li FY, Zhou RX. Unusual case of gallstones with chronic cholecystitis revealing a metachronous gallbladder metastasis from renal clear cell carcinoma[J]. ANZ J Surg, 2020, 90(4): E87-E88. [15] Udager AM, Rungta SA. Metastatic renal cell carcinoma, clear cell type, of the parotid gland: a case report, review of literature, and proposed algorithmic approach to salivary gland clear cell neoplasms in fine-needle aspiration biopsies[J]. Diagn Cytopathol, 2014, 42(11): 974-983. [16] 张凯, 朱刚. 2020版EAU肾细胞癌诊疗指南更新解读之二[J]. 中华泌尿外科杂志, 2020, 41(8): 578-580. ZHANG Kai, ZHU Gang. The update interpretation of 2020 EAU renal cell carcinoma guideline(Part Ⅱ)[J]. Chinese Journal of Urology, 2020, 41(8): 578-580. [17] Albiges L, Tannir NM, Burotto M, et al. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial[J]. ESMO Open, 2020, 5(6): e001079. [18] Rini BI, Plimack ER, Stus V, et al. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma[J]. N Engl J Med, 2019, 380(12): 1116-1127. [19] Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma[J]. N Engl J Med, 2018, 378(14): 1277-1290. [20] Choueiri TK, Hessel C, Halabi S, et al. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk(Alliance A031203 CABOSUN randomised trial): progression-free survival by independent review and overall survival update[J]. Eur J Cancer, 2018, 94: 115-125. doi:10.1016/j.ejca.2018.02.012. [21] Powles T, Motzer RJ, Albiges L, et al. Outcomes by IMDC risk in the COSMIC-313 phase 3 trial evaluating cabozantinib(C)plus nivolumab(N)and ipilimumab(I)in first-line advanced RCC(aRCC)of IMDC intermediate or poor risk[J]. J Clin Oncol, 2023, 41(6_suppl): 605. |
| [1] | 吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84. |
| [2] | 杨文欣,刘英姣,高雅,杨安逸,周恒宇,高俊茶. 以急性胰腺炎为首发表现的急性髓系白血病1例并文献复习[J]. 山东大学学报 (医学版), 2023, 61(7): 109-117. |
| [3] | 靳新娟,蔡大幸,范金蕾,邓展昊,李楠,于德新,李安宁. 显微镜高分辨率MRI鉴别皮肤良、恶性局灶隆起性结节[J]. 山东大学学报 (医学版), 2023, 61(12): 51-61. |
| [4] | 孙文雄,吴日超,郑贤静,李丽, 张友忠. 宫颈血管周上皮样细胞肿瘤1例[J]. 山东大学学报 (医学版), 2022, 60(9): 125-128. |
| [5] | 查菁,郭婧,左秀丽. 少见类型肠梗阻病因病例报告1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 130-132. |
| [6] | 李祥泽,王先明,宋歌声,崔晶,孙凯,王皓晨,王天成,韩绍奇,田虎. 合并乙肝肝硬化的肝上皮样血管内皮瘤1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(11): 89-95. |
| [7] | 李宏宇,孙明霞,于璐,孙朝阳,彭化海,张风河,谈万业. 先天性颌下腺导管扩张症1例及文献分析[J]. 山东大学学报 (医学版), 2022, 60(11): 121-123. |
| [8] | 陆梓文,李光兵,郑顺贞,杨洋,刘军. 肝脏胆管腺纤维瘤1例报道[J]. 山东大学学报 (医学版), 2021, 59(11): 120-122. |
| [9] | 刘朝娣,邓凯,靳先文,宋歌声,张成琪. 能谱CT对卵巢原发良恶性肿瘤的鉴别[J]. 山东大学学报 (医学版), 2017, 55(12): 43-50. |
| [10] | 徐志宏,刘荣凤,王晓翔,冯莉,姚铁柱,刘红. 养正消积胶囊联合化疗治疗转移性乳腺癌的临床疗效及安全性[J]. 山东大学学报（医学版）, 2016, 54(5): 79-83. |
| [11] | 李进叶,宋歌声,宋吉清,王大伟,靳先文,张成琪. 宝石能谱CT与常规超声对甲状腺结节良恶性诊断价值的对照分析[J]. 山东大学学报（医学版）, 2016, 54(3): 81-86. |
| [12] | 贾振军, 曲勇, 张世杰. HER2和p53在胃腺癌不同衍变阶段中的表达及意义[J]. 山东大学学报（医学版）, 2015, 53(3): 73-76. |
| [13] | 徐翠, 王涛, 周平. 儿童幽门螺杆菌免疫组化染色检测分析[J]. 山东大学学报（医学版）, 2014, 52(9): 81-84. |
| [14] | 李玲, 王丽丽, 王胜江, 于超, 刘延鹏, 徐成伟. 乳腺癌患者血浆D-二聚体水平与预后关系的探讨[J]. 山东大学学报（医学版）, 2014, 52(9): 77-80. |
| [15] | 许加军, 刘宗现, 许风雷, 王磊, 孔维华. 自噬相关蛋白4EBP1与eIF4E在几种常见脑瘤组织中的表达[J]. 山东大学学报（医学版）, 2014, 52(9): 72-76. |
|
